CA
PFE icon

Capitolis Advisors’s Pfizer PFE Stock Holding History

Capitolis Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-506,602
Closed -$26.2M – 145
2022
Q1 		$26.2M Sell
506,602
-872,636
-63% -$45.3M 1.32% 25
2021
Q4 		$81.4M Buy
1,379,238
+70,893
+5% +$3.51M 0.49% 49
2021
Q3 		$54.1M Sell
1,308,345
-13,709
-1% -$607K 0.49% 50
2021
Q2 		$51.8M Buy
1,322,054
+470,639
+55% +$18.3M 0.61% 41
2021
Q1 		$30.8M Buy
851,415
+507,357
+147% +$18M 0.53% 43
2020
Q4 		$12.7M Buy
+344,058
New +$12.6M 0.21% 115

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capitolis Advisors's PFE Position: Q2 2022 in Review

Capitolis Advisors sold out of Pfizer (PFE) in Q2 2022, closing a stake of 506,602 shares — an estimated $26.2M sold.

Capitolis Advisors first reported a position in PFE in Q4 2020 and held it in 6 quarters. The position peaked at $81.4M in Q4 2021. 3,157 funds tracked by Wall St. Rank hold PFE as of Q2 2022.

  • Capitolis Advisors reported no remaining Pfizer position as of Q2 2022 after selling out during the quarter.
  • Capitolis Advisors sold 506,602 Pfizer shares in Q2 2022, an estimated $26.2M.
  • Capitolis Advisors first reported a position in Pfizer in Q4 2020 and held it in 6 quarters.
  • Capitolis Advisors's Pfizer position peaked at $81.4M in Q4 2021.
  • 3,157 funds tracked by Wall St. Rank held Pfizer as of Q2 2022.

Based on Capitolis Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.